Cash flow Harmony Biosciences Holdings, Inc.

Equities

HRMY

US4131971040

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2026-01-22 pm EST			5-day change	1st Jan Change
36.76 ^USD	+0.19%		+0.96%	-1.76%

Jan. 13	Harmony Biosciences Holdings, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 04:30 PM
Jan. 12	Harmony Biosciences guides to over $1 billion in Wakix® revenue in 2026 advancing robust late-stage pipeline with potential for long-term value creation	RE

08951be027f3e1c77042.8xi8Pthi81EOJi4qWGkhaRvujgHftFkeNeLLyEIkeLQ.hSv_CagmvjhcY1pzOi4RKGmL_kfr0zR8TLWerDYUSvKAf497mTuwBTxfYw

Published financial data: HARMONY BIOSCIENCES HOLDINGS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	160M	305M	438M	582M	715M
Total Revenues	160M	305M	438M	582M	715M
Cost of Goods Sold, Total	27.74M	55.52M	83.48M	121M	157M
Gross Profit	132M	250M	354M	461M	558M
Selling General & Admin Expenses, Total	95.57M	132M	163M	193M	221M
R&D Expenses	19.45M	30.37M	70.89M	76.06M	146M
Other Operating Expenses, Total	115M	162M	234M	269M	367M
Operating Income	16.99M	87.53M	120M	192M	191M
Interest Expense, Total	-28.22M	-23.97M	-18.8M	-23.76M	-17.5M
Interest And Investment Income	-	-	3.13M	14.73M	18.54M
Net Interest Expenses	-28.22M	-23.97M	-15.67M	-9.03M	1.05M
Other Non Operating Income (Expenses)	-3.07M	16K	169K	159K	-68K
EBT, Excl. Unusual Items	-14.3M	63.57M	105M	183M	192M
Other Unusual Items	-22.64M	-26.15M	-	-9.77M	-
EBT, Incl. Unusual Items	-36.94M	37.43M	105M	173M	192M
Income Tax Expense	-	2.83M	-76.78M	44.54M	46.31M
Earnings From Continuing Operations	-36.94M	34.6M	181M	129M	145M
Net Income to Company	-36.94M	34.6M	181M	129M	145M
Net Income - (IS)	-36.94M	34.6M	181M	129M	145M
Preferred Dividend and Other Adjustments	26.9M	-	-	-	-
Net Income to Common Incl Extra Items	-63.85M	34.6M	181M	129M	145M
Net Income to Common Excl. Extra Items	-63.85M	34.6M	181M	129M	145M
Per Share Items
Net EPS - Basic	-2.48	0.6	3.07	2.17	2.56
Basic EPS - Continuing Operations	-2.48	0.6	3.07	2.17	2.56
Basic Weighted Average Shares Outstanding	25.77M	57.53M	59.17M	59.47M	56.89M
Net EPS - Diluted	-2.48	0.58	2.97	2.13	2.51
Diluted EPS - Continuing Operations	-2.48	0.58	2.97	2.13	2.51
Diluted Weighted Average Shares Outstanding	25.77M	59.21M	61.1M	60.37M	57.87M
Normalized Basic EPS	-0.35	0.69	1.11	1.92	2.11
Normalized Diluted EPS	-0.35	0.67	1.07	1.9	2.07
Supplemental Items
EBITDA	27.22M	106M	144M	216M	215M
EBITA	26.83M	106M	143M	216M	215M
EBIT	16.99M	87.53M	120M	192M	191M
EBITDAR	27.91M	108M	145M	218M	217M
Effective Tax Rate - (Ratio)	-	7.56	-73.34	25.69	24.14
Current Domestic Taxes	-	2.83M	9.16M	57.96M	-
Total Current Taxes	-	2.83M	9.16M	57.96M	74.31M
Deferred Domestic Taxes	-	0	-85.94M	-13.42M	-
Total Deferred Taxes	-	0	-85.94M	-13.42M	-28M
Normalized Net Income	-8.94M	39.73M	65.43M	114M	120M
Interest on Long-Term Debt	28.62M	24.19M	18.8M	23.76M	17.5M
Supplemental Operating Expense Items
Advertising Expense	13.3M	19.56M	22.43M	21.54M	27.56M
Selling and Marketing Expenses	55.82M	68.12M	79.28M	97.4M	111M
General and Administrative Expenses	39.75M	63.91M	84.02M	95.29M	110M
Research And Development Expense From Footnotes	31.29M	30.37M	70.89M	78.32M	163M
Net Rental Expense, Total	686K	1.2M	1.53M	1.81M	2.1M
Imputed Operating Lease Interest Expense	1.06M	1.18M	1.18M	1.76M	1.56M
Imputed Operating Lease Depreciation	-374K	15.24K	349K	47.38K	542K
Stock-Based Comp., R&D Exp. (Total)	586K	2.12M	2.61M	3.96M	6.68M
Stock-Based Comp., S&M Exp. (Total)	703K	3.1M	3.89M	5.15M	7.44M
Stock-Based Comp., G&A Exp. (Total)	3.9M	10.88M	20.4M	22.1M	28.58M
Stock-Based Comp., Other (Total)	-	-	-	499K	-
Total Stock-Based Compensation	5.19M	16.1M	26.9M	31.7M	42.7M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	229M	234M	244M	312M	453M
Short Term Investments	-	-	79.33M	41.8M	14.18M
Total Cash And Short Term Investments	229M	234M	323M	353M	467M
Accounts Receivable, Total	22.18M	34.84M	54.74M	74.14M	83.03M
Total Receivables	22.18M	34.84M	54.74M	74.14M	83.03M
Inventory	3.82M	4.43M	4.3M	5.36M	7.2M
Prepaid Expenses	6.96M	7.64M	9.35M	12.57M	13.71M
Other Current Assets, Total	1.3M	3.22M	8.79M	5.54M	8.12M
Total Current Assets	263M	284M	400M	451M	579M
Net Property Plant And Equipment	938K	4.12M	2.88M	2.72M	3.38M
Long-term Investments	-	-	22.57M	72.17M	109M
Other Intangibles, Total	162M	144M	161M	137M	113M
Deferred Tax Assets Long-Term	-	-	85.94M	144M	190M
Other Long-Term Assets, Total	902K	967K	1.24M	4.22M	4.03M
Total Assets	427M	433M	674M	811M	999M
Liabilities
Accounts Payable, Total	2.56M	1M	3.79M	17.73M	13.74M
Accrued Expenses, Total	31.67M	49.41M	71.47M	123M	139M
Current Portion of Long-Term Debt	-	2M	2M	15M	16.25M
Current Portion of Leases	-	-	1.61M	1.44M	1.32M
Other Current Liabilities	100M	1.36M	10K	6.37M	4.35M
Total Current Liabilities	135M	53.78M	78.88M	164M	175M
Long-Term Debt	194M	190M	190M	179M	163M
Long-Term Leases	-	2.23M	975K	1.08M	822K
Other Non Current Liabilities	1.1M	944K	1.53M	1.03M	1.12M
Total Liabilities	330M	247M	271M	344M	340M
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	1K	1K	1K	1K	1K
Additional Paid In Capital	585M	640M	675M	610M	657M
Retained Earnings	-488M	-454M	-272M	-143M	2.22M
Comprehensive Income and Other	-	-	-151K	2K	66K
Total Common Equity	97.18M	187M	403M	467M	659M
Total Equity	97.18M	187M	403M	467M	659M
Total Liabilities And Equity	427M	433M	674M	811M	999M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	56.89M	58.87M	59.62M	56.77M	57.35M
ECS Total Common Shares Outstanding	56.89M	58.83M	59.62M	56.77M	57.14M
Book Value / Share	1.71	3.17	6.76	8.23	11.53
Tangible Book Value	-65.16M	42.59M	242M	330M	546M
Tangible Book Value Per Share	-1.15	0.72	4.06	5.81	9.55
Total Debt	194M	194M	194M	196M	181M
Net Debt	-34.38M	-40.09M	-129M	-157M	-286M
Debt Equivalent Oper. Leases	5.49M	9.58M	12.21M	14.49M	16.79M
Account Code - Inventory Valuation	5	5	8	8	8
Inventories - Raw Materials, Total	396K	986K	838K	1.06M	944K
Inventories - Work In Process, Total	2.66M	1.79M	1.51M	2.02M	3.49M
Inventories - Finished Goods, Total	941K	2.11M	2.56M	2.28M	2.76M
Full Time Employees	150	180	200	246	268

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-36.94M	34.6M	181M	129M	145M
Depreciation & Amortization - CF	394K	416K	419K	514K	267K
Amortization of Goodwill and Intangible Assets - (CF)	9.84M	18.42M	22.97M	23.84M	23.84M
Depreciation & Amortization, Total	10.24M	18.84M	23.38M	24.36M	24.11M
Amortization of Deferred Charges, Total - (CF)	2.41M	2.24M	1.66M	2.27M	700K
(Gain) Loss on Sale of Investments - (CF)	-	-	-432K	-2.72M	-2.26M
Asset Writedown & Restructuring Costs	2M	-	-	2.26M	43.6M
Stock-Based Compensation (CF)	4.69M	15.66M	26.17M	31.7M	42.6M
Other Operating Activities, Total	26.24M	26.59M	-83.68M	-2.38M	-27.1M
Change In Accounts Receivable	-17.92M	-12.67M	-19.9M	-19.4M	-8.89M
Change In Inventories	-2.74M	-609K	135K	-1.07M	-1.84M
Change In Accounts Payable	-3.8M	-1.56M	2.78M	8.95M	-5.38M
Change in Other Net Operating Assets	12.83M	15.46M	12.87M	46.55M	8.79M
Cash from Operations	-2.98M	98.56M	144M	219M	220M
Capital Expenditure	-2K	-298K	-172K	-312K	-1.15M
Cash Acquisitions	-	-	-	-36.97M	-33.07M
Sale (Purchase) of Intangible assets	-2M	-100M	-40M	-	-26.5M
Investment in Marketable and Equity Securities, Total	-	-	-102M	-9.16M	-6.76M
Cash from Investing	-2M	-100M	-142M	-46.44M	-67.48M
Long-Term Debt Issued, Total	200M	200M	-	200M	-
Total Debt Issued	200M	200M	-	200M	-
Long-Term Debt Repaid, Total	-103M	-200M	-2M	-201M	-15M
Total Debt Repaid	-103M	-200M	-2M	-201M	-15M
Issuance of Common Stock	148M	39.37M	8.84M	5.06M	6.5M
Repurchase of Common Stock	-184K	-	-	-101M	-2.5M
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-36.04M	-31.45M	-	-8.84M	-
Cash from Financing	209M	7.42M	6.84M	-106M	-11M
Net Change in Cash	204M	5.68M	9.48M	67.4M	141M
Supplemental Items
Cash Interest Paid	26.2M	19.83M	16.36M	20.05M	17.32M
Cash Income Tax Paid (Refund)	-	2.88M	12.64M	48.23M	79.64M
Levered Free Cash Flow	96.24M	-122M	72.97M	215M	144M
Unlevered Free Cash Flow	111M	-109M	83.05M	227M	154M
Change In Net Working Capital	-87.43M	98.63M	2.18M	-51.63M	4.29M
Net Debt Issued / Repaid	97.46M	-500K	-2M	-1.25M	-15M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.98	12.71	13.57	16.16	13.17
Return on Total Capital	5.62	16.28	15.34	19.05	15.86
Return On Equity %	-86.32	24.39	61.58	29.63	25.84
Return on Common Equity	39.21	24.39	61.58	29.63	25.84
Margin Analysis
Gross Profit Margin %	82.64	81.82	80.93	79.17	78.06
SG&A Margin	59.83	43.23	37.3	33.11	30.96
EBITDA Margin %	17.04	34.82	32.79	37.18	30.07
EBITA Margin %	16.8	34.69	32.69	37.09	30.04
EBIT Margin %	10.63	28.66	27.45	32.99	26.7
Income From Continuing Operations Margin %	-23.13	11.33	41.44	22.14	20.36
Net Income Margin %	-23.13	11.33	41.44	22.14	20.36
Net Avail. For Common Margin %	-39.97	11.33	41.44	22.14	20.36
Normalized Net Income Margin	-5.6	13.01	14.94	19.67	16.77
Levered Free Cash Flow Margin	60.25	-39.95	16.66	36.91	20.13
Unlevered Free Cash Flow Margin	69.78	-35.78	18.97	39.07	21.57
Asset Turnover
Asset Turnover	0.6	0.71	0.79	0.78	0.79
Fixed Assets Turnover	140.87	120.82	125.05	207.86	234.57
Receivables Turnover (Average Receivables)	12.09	10.71	9.78	9.03	9.09
Inventory Turnover (Average Inventory)	11.3	13.45	19.13	25.1	24.97
Short Term Liquidity
Current Ratio	1.95	5.29	5.07	2.75	3.31
Quick Ratio	1.86	5.01	4.79	2.61	3.14
Operating Cash Flow to Current Liabilities	-0.02	1.83	1.83	1.34	1.26
Days Sales Outstanding (Average Receivables)	30.28	34.07	37.34	40.41	40.24
Days Outstanding Inventory (Average Inventory)	32.4	27.14	19.08	14.54	14.66
Average Days Payable Outstanding	53.54	11.57	10.48	32.11	36.3
Cash Conversion Cycle (Average Days)	9.14	49.64	45.94	22.85	18.6
Long Term Solvency
Total Debt/Equity	199.89	104.13	48.22	41.99	27.52
Total Debt / Total Capital	66.65	51.01	32.53	29.57	21.58
LT Debt/Equity	199.89	103.06	47.32	38.47	24.86
Long-Term Debt / Total Capital	66.65	50.49	31.93	27.09	19.49
Total Liabilities / Total Assets	77.25	56.97	40.22	42.45	34.03
EBIT / Interest Expense	0.6	3.65	6.39	8.08	10.91
EBITDA / Interest Expense	0.96	4.49	7.72	9.18	12.4
(EBITDA - Capex) / Interest Expense	0.96	4.48	7.71	9.17	12.34
Total Debt / EBITDA	7.14	1.81	1.34	0.9	0.84
Net Debt / EBITDA	-1.26	-0.37	-0.89	-0.72	-1.32
Total Debt / (EBITDA - Capex)	7.14	1.81	1.34	0.9	0.84
Net Debt / (EBITDA - Capex)	-1.26	-0.37	-0.89	-0.72	-1.32
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.56K	91.21	43.35	32.93	22.8
Gross Profit, 1 Yr. Growth %	2.89K	89.33	41.79	30.03	21.08
EBITDA, 1 Yr. Growth %	-119.55	290.73	34.98	50.72	-0.67
EBITA, 1 Yr. Growth %	-119.22	294.92	35.11	50.8	-0.56
EBIT, 1 Yr. Growth %	-111.93	415.29	37.31	59.78	-0.63
Earnings From Cont. Operations, 1 Yr. Growth %	-75.69	-193.65	424.52	-28.99	12.91
Net Income, 1 Yr. Growth %	-75.69	-193.65	424.52	-28.99	12.91
Normalized Net Income, 1 Yr. Growth %	-90.37	-544.42	64.67	74.96	4.72
Diluted EPS Before Extra, 1 Yr. Growth %	-89.7	-123.39	412.07	-28.28	17.84
Accounts Receivable, 1 Yr. Growth %	421.18	57.12	57.1	35.44	11.99
Inventory, 1 Yr. Growth %	251.38	15.93	-3.05	24.81	34.22
Net Property, Plant and Equip., 1 Yr. Growth %	-29.47	339.02	-29.94	-5.89	24.46
Total Assets, 1 Yr. Growth %	300.25	1.49	55.47	20.42	23.14
Tangible Book Value, 1 Yr. Growth %	-86.84	-165.36	467.97	36.38	65.48
Common Equity, 1 Yr. Growth %	-122.98	91.92	115.99	15.93	41.15
Cash From Operations, 1 Yr. Growth %	-96.04	-3.4K	46.58	51.86	0.2
Capital Expenditures, 1 Yr. Growth %	-98.66	14.8K	-42.28	81.4	269.55
Levered Free Cash Flow, 1 Yr. Growth %	-148.74	-226.79	-159.07	194.43	-32.86
Unlevered Free Cash Flow, 1 Yr. Growth %	-157.38	-198.04	-175.06	173.82	-32.07
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	613.79	65.56	38.04	27.76
Gross Profit, 2 Yr. CAGR %	-	652.12	63.85	35.78	25.47
EBITDA, 2 Yr. CAGR %	-18.77	-13.66	129.65	42.63	22.36
EBITA, 2 Yr. CAGR %	-19.54	-13.95	130.99	42.74	22.46
EBIT, 2 Yr. CAGR %	-35.98	-22.55	166	48.12	26.01
Earnings From Cont. Operations, 2 Yr. CAGR %	-3.77	-52.29	121.63	92.99	-10.46
Net Income, 2 Yr. CAGR %	-3.77	-52.29	121.63	92.99	-10.46
Normalized Net Income, 2 Yr. CAGR %	-40.12	-35.32	170.52	69.74	35.36
Diluted EPS Before Extra, 2 Yr. CAGR %	-44.01	-84.48	9.43	91.64	-8.07
Accounts Receivable, 2 Yr. CAGR %	-	186.16	57.11	45.87	23.16
Inventory, 2 Yr. CAGR %	-	101.83	6.02	10	29.43
Net Property, Plant and Equip., 2 Yr. CAGR %	-22.85	75.96	75.38	-18.8	8.22
Total Assets, 2 Yr. CAGR %	118.71	101.55	25.61	36.82	21.77
Tangible Book Value, 2 Yr. CAGR %	-48.18	-70.67	92.67	178.32	50.23
Common Equity, 2 Yr. CAGR %	-36.72	-33.59	103.6	58.24	27.92
Cash From Operations, 2 Yr. CAGR %	-72.26	14.3	595.68	49.2	23.35
Capital Expenditures, 2 Yr. CAGR %	-96.14	41.42	827.36	2.32	158.91
Levered Free Cash Flow, 2 Yr. CAGR %	-	-21.82	-12.82	31.88	40.44
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-25.41	-13.68	43.36	36.24
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	318	53.88	32.76
Gross Profit, 3 Yr. CAGR %	-	-	331.27	51.69	30.69
EBITDA, 3 Yr. CAGR %	-	37.12	0.2	99.57	26.43
EBITA, 3 Yr. CAGR %	-	36.74	0.01	100.39	26.54
EBIT, 3 Yr. CAGR %	-	28.31	-6.26	124.44	29.67
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-4.64	6.09	51.65	61.41
Net Income, 3 Yr. CAGR %	-	-4.64	6.09	51.65	61.41
Normalized Net Income, 3 Yr. CAGR %	-	16.8	-11.68	133.95	44.5
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-58.15	-50.22	-4.94	62.96
Accounts Receivable, 3 Yr. CAGR %	-	-	134.32	49.53	33.57
Inventory, 3 Yr. CAGR %	-	-	58.07	11.94	17.54
Net Property, Plant and Equip., 3 Yr. CAGR %	-	37.73	29.45	42.51	-6.38
Total Assets, 3 Yr. CAGR %	-	69.33	84.84	23.86	32.1
Tangible Book Value, 3 Yr. CAGR %	-	-44.01	-21.24	71.71	134.03
Common Equity, 3 Yr. CAGR %	-	-8.4	-1.6	68.75	52.32
Cash From Operations, 3 Yr. CAGR %	-	36.44	24.18	318.88	30.66
Capital Expenditures, 3 Yr. CAGR %	-	-39.44	4.9	438.32	56.99
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-28.5	30.8	5.22
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-24.95	26.83	11.69
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	160.18
Gross Profit, 5 Yr. CAGR %	-	-	-	-	163.19
EBITDA, 5 Yr. CAGR %	-	-	-	39.3	8.54
EBITA, 5 Yr. CAGR %	-	-	-	39.11	8.45
EBIT, 5 Yr. CAGR %	-	-	-	35.89	5.52
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	26.42	-0.87
Net Income, 5 Yr. CAGR %	-	-	-	26.42	-0.87
Normalized Net Income, 5 Yr. CAGR %	-	-	-	35.64	4.76
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-23.08	-36.37
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	81.16
Inventory, 5 Yr. CAGR %	-	-	-	-	45.92
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	11.49	20.5
Total Assets, 5 Yr. CAGR %	-	-	-	55.49	56.42
Tangible Book Value, 5 Yr. CAGR %	-	-	-	6.33	1.97
Common Equity, 5 Yr. CAGR %	-	-	-	13.99	9.28
Cash From Operations, 5 Yr. CAGR %	-	-	-	41.41	23.85
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-25.31	50.57
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-6.34
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-4.73